SAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the submission of public comments to the Food and Drug Administration (FDA) concerning its proposed rule
Sixth-Generation Device Automatically Adapts to All Environments for an Enhanced Hearing Experience LAS VEGAS, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss , today launched Eargo 6, its
